ERBB2 and breast carcinoma: Palbociclib, Trastuzumab, Lapatinib and Fulvestrant Treatment in Patients With Brain Metastasis From ER Positive, HER‐2 Positive Breast Cancer: A Multi‐center, Prospective Study in China